TipRanks
Kyowa Kirin Co Ltd (JP:4151)
:4151
Japanese Market
4151
Kyowa Kirin Co
RESEARCH TOOLSreports
Want to see JP:4151 full AI Analyst Report?

Kyowa Kirin Co (4151) Stock News & Sentiment

2 Followers
Kyowa Kirin’s KK4277 Lupus Trial Completion: What Investors Should Watch Next
Premium
Company Announcements
Kyowa Kirin’s KK4277 Lupus Trial Completion: What Investors Should Watch Next
6d ago
KYKOF
Kyowa Kirin’s New Blood Cancer Trial: What KK2430 Could Mean for KYKOF Investors
Premium
Company Announcements
Kyowa Kirin’s New Blood Cancer Trial: What KK2430 Could Mean for KYKOF Investors
2M ago
KYKOF
Kyowa Kirin Co (KYKOF) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Kyowa Kirin Co (KYKOF) Q2 Earnings Cheat Sheet
2M ago
KYKOF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
KYKOF Upcoming Earnings Report: What to Expect?
8M ago
Kyowa Kirin’s Poteligeo Study: A Closer Look at Market Implications
Premium
Company Announcements
Kyowa Kirin’s Poteligeo Study: A Closer Look at Market Implications
11M ago
KYKOF
Kyowa Kirin’s New Clinical Trial: A Potential Game-Changer in T-Cell Lymphoma Treatment
Premium
Company Announcements
Kyowa Kirin’s New Clinical Trial: A Potential Game-Changer in T-Cell Lymphoma Treatment
11M ago
KYKOF
Kyowa Kirin’s Promising Study on KHK4951 for Diabetic Macular Edema
Premium
Company Announcements
Kyowa Kirin’s Promising Study on KHK4951 for Diabetic Macular Edema
11M ago
KYKOF
More JP:4151 News >

4151 News on the Web

Kyowa Kirin Co (KYKOF) Q2 Earnings Cheat Sheet
TipRanks News
Neutral
Kyowa Kirin downgraded to Sell from Buy at Citi
TipRanks News
Bearish
Kyowa Kirin downgraded to Underweight from Equal Weight at Morgan Stanley
TipRanks News
Bearish
Kyowa Kirin downgraded to Neutral from Outperform at SMBC Nikko
TipRanks News
Neutral
Kyowa Kirin downgraded to Underweight from Neutral at JPMorgan
TipRanks News
Bearish
Kyowa Kirin announces discontinuation of rocatinlimab clinical trials
TipRanks News
Bearish
KYKOF Upcoming Earnings Report: What to Expect?
TipRanks News
Neutral
Kyowa Kirin to regain control of rocatinlimab development, commercialization
TipRanks News
Neutral

News Score - Last 7 Days

Positive
JP:4151
Sector Average
Media Buzz
This Week3 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4151’s Media Buzz Sentiment?
3 articles about JP:4151 were published this week. In an average week, 0.25 articles are published.
    What is JP:4151’s weekly average amount of articles?
    In an average week, 0.25 articles about JP:4151 are published.
      What is JP:4151’s News Sentiment?
      100% of articles about JP:4151 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        ABTAbbott Laboratories
        INCYIncyte
        SMMTSummit Therapeutics
        CRVOCervoMed
        Showing the stocks with the most bullish news sentiment over the past week